Dr Reddys Laboratories Share Price Today - Live Blog for December 17, 2025

Dr Reddys Laboratories Ltd's share price remained flat, currently at ₹1,271.00. This sustained performance provides investors with an opportunity to assess whether the stock aligns with their investment objectives.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.02% boost, with the current market value at ₹1,272.25 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd's stock has surged by 0.03%, and it is currently trading at ₹1,272.00. Additionally, the stock maintains a PE ratio of 18.6100, while the industry PE is 33.2821.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.28%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,272.00 per share.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.13% drop, and it's now trading at ₹1,268.05 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.09%, reaching the current market price of ₹1,269.30. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

After a notable 0.09% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,269.30. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

The share price of Dr Reddys Laboratories Ltd plunged by -0.01%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,269.30, but investors are assessing whether this is a temporary dip or a long-term trend.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.09%, signalling a challenging period. Currently trading at ₹1,269.40, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd experienced a -0.26% dip in its share price and is currently trading at ₹1,269.70. The stock has a PE ratio of 18.6100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

With a -0.27% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,273.00. The stock is currently trading at a PE of 18.6100, while the industry PE is 33.2821, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's stock price surged by 0.04%, reaching the current market value of ₹1,276.30 per share. This surge is a testament to the stock's recent performance.

The share price of Dr Reddys Laboratories Ltd experienced a -0.14% slump and is currently trading at ₹1,275.85. While the stock maintains a PE ratio of 18.6100, the industry PE is 33.2821, raising questions about valuation.

Dr Reddys Laboratories Ltd's shares experienced a 0.02% uptick, and they are currently valued at ₹1,278.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.14%, signalling a challenging period. Currently trading at ₹1,277.70, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Dr Reddys Laboratories Ltd is facing a -0.02% decline and is currently trading at ₹1,278.05 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.23% upswing, and it's currently trading at ₹1,278.25 per share. Investors are closely watching this development.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.36%. At this moment, it's actively trading at ₹1,274.75, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd's stock price surged by 0.09%, reaching the current market value of ₹1,270.15 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd experienced a -0.06% dip in its share price and is currently trading at ₹1,269.50. The stock has a PE ratio of 18.6100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.04% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,272.40 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's stock has surged by 0.04%, and it is currently trading at ₹1,272.40. Additionally, the stock maintains a PE ratio of 18.6100, while the industry PE is 33.2821.

After a significant 0.04% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,271.65 in the current market. This upward movement is attracting attention from both retail and institutional investors.

With a -0.13% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,271.35. The stock is currently trading at a PE of 18.6100, while the industry PE is 33.2821, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd share price surged by 0.07%. With its current market price standing at ₹1,274.65 per share, this stock is garnering increased attention from the investment community.

With a -0.51% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,271.70. Investors should examine the factors driving this decline. The stock's PE ratio is 18.6100, whereas the industry PE ratio stands at 33.2821.